Latest Electra Therapeutics News & Updates

See the latest news and media coverage for Electra Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Electra Therapeutics

Clinical-stage biotechnology company developing immune-targeted medicines

electra-therapeutics.com
Company type
Private company
Number of employees
46–50
Industry
Pharmaceuticals

Last updated

Latest news about Electra Therapeutics

In short: Electra Therapeutics priced a $350 million IPO and reported $402.5 million in third-quarter cash.

Company announcements

Electra Therapeutics

Electra Therapeutics initiates Phase 1 trial of ELA822

The randomized, placebo-controlled, single-ascending-dose study evaluates safety, tolerability, pharmacokinetics and pharmacodynamics of the SIRPγ-specific antibody in healthy volunteers.

Electra Therapeutics

Electra Therapeutics promotes Chris Clark to Chief Financial Officer

He joined in December 2025 as Executive Vice President, Strategy and Finance and brings more than two decades of life sciences investment experience.

Unlock all announcements with a

Media coverage

Law360

Cooley, Latham Prep Electra Therapeutics' $325M IPO Plan - Law360

Biotechnology firm Electra Therapeutics plans to make its public debut this week through an estimated $325 million initial public offering steered by Cooley LLP and...

Unlock all articles with a

Never miss news about Electra Therapeutics

Track Electra Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.